186 related articles for article (PubMed ID: 11180503)
1. Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.
Cho AK; Melega WP; Kuczenski R; Segal DS
Synapse; 2001 Feb; 39(2):161-6. PubMed ID: 11180503
[TBL] [Abstract][Full Text] [Related]
2. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
O'Neil ML; Kuczenski R; Segal DS; Cho AK; Lacan G; Melega WP
Synapse; 2006 Nov; 60(6):465-73. PubMed ID: 16897726
[TBL] [Abstract][Full Text] [Related]
3. Human methamphetamine pharmacokinetics simulated in the rat: single daily intravenous administration reveals elements of sensitization and tolerance.
Segal DS; Kuczenski R
Neuropsychopharmacology; 2006 May; 31(5):941-55. PubMed ID: 16123749
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling.
Melega WP; Cho AK; Harvey D; Laćan G
Synapse; 2007 Apr; 61(4):216-20. PubMed ID: 17230548
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat.
Rivière GJ; Byrnes KA; Gentry WB; Owens SM
J Pharmacol Exp Ther; 1999 Dec; 291(3):1220-6. PubMed ID: 10565845
[TBL] [Abstract][Full Text] [Related]
6. Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats.
Milesi-Hallé A; Hendrickson HP; Laurenzana EM; Gentry WB; Owens SM
Toxicol Appl Pharmacol; 2005 Dec; 209(3):203-13. PubMed ID: 15916788
[TBL] [Abstract][Full Text] [Related]
7. Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration.
Rivière GJ; Gentry WB; Owens SM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1042-7. PubMed ID: 10688621
[TBL] [Abstract][Full Text] [Related]
8. Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.
Kuczenski R; Segal DS; Melega WP; Lacan G; McCunney SJ
Neuropsychopharmacology; 2009 Oct; 34(11):2430-41. PubMed ID: 19571794
[TBL] [Abstract][Full Text] [Related]
9. Methods in drug abuse models: comparison of different models of methamphetamine paradigms.
Kobeissy FH; Mitzelfelt JD; Fishman I; Morgan D; Gaskins R; Zhang Z; Gold MS; Wang KK
Methods Mol Biol; 2012; 829():269-78. PubMed ID: 22231820
[TBL] [Abstract][Full Text] [Related]
10. Effects of prenatal exposure to methamphetamine on the development of the rat retina.
Melo P; Rodrigues LG; Silva MC; Tavares MA
Ann N Y Acad Sci; 2006 Aug; 1074():590-603. PubMed ID: 17105955
[TBL] [Abstract][Full Text] [Related]
11. (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration.
Gentry WB; Ghafoor AU; Wessinger WD; Laurenzana EM; Hendrickson HP; Owens SM
Pharmacol Biochem Behav; 2004 Dec; 79(4):751-60. PubMed ID: 15582684
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetic behavioral changes of methamphetamine in methamphetamine-sensitized animal model].
Kitaichi K; Morishita Y; Hasegawa T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Nov; 21(5):133-44. PubMed ID: 11797416
[TBL] [Abstract][Full Text] [Related]
13. Human pharmacology of the methamphetamine stereoisomers.
Mendelson J; Uemura N; Harris D; Nath RP; Fernandez E; Jacob P; Everhart ET; Jones RT
Clin Pharmacol Ther; 2006 Oct; 80(4):403-20. PubMed ID: 17015058
[TBL] [Abstract][Full Text] [Related]
14. The altered disposition of methamphetamine in the model of methamphetamine-induced neurotoxicity.
Kitaichi K; Ito Y; Fukuda M; Aoyama N; Nakayama H; Takagi K; Hasegawa T
Ann N Y Acad Sci; 2004 Oct; 1025():248-56. PubMed ID: 15542724
[TBL] [Abstract][Full Text] [Related]
15. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
Clemens KJ; McGregor IS; Hunt GE; Cornish JL
Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
[TBL] [Abstract][Full Text] [Related]
16. Development of a liquid chromatography-tandem mass spectrometric method for the determination of methamphetamine and amphetamine using small volumes of rat serum.
Hendrickson HP; Milesi-Hallé A; Laurenzana EM; Owens SM
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jul; 806(2):81-7. PubMed ID: 15171915
[TBL] [Abstract][Full Text] [Related]
17. Effects of postnatal exposure to methamphetamine on the development of the rat retina.
Rodrigues LG; Melo P; Silva MC; Tavares MA
Ann N Y Acad Sci; 2006 Aug; 1074():604-19. PubMed ID: 17105956
[TBL] [Abstract][Full Text] [Related]
18. Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain.
Kaewsuk S; Sae-ung K; Phansuwan-Pujito P; Govitrapong P
Neurochem Int; 2009 Nov; 55(6):397-405. PubMed ID: 19409439
[TBL] [Abstract][Full Text] [Related]
19. High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus.
Bowyer JF; Ali S
Synapse; 2006 Dec; 60(7):521-32. PubMed ID: 16952162
[TBL] [Abstract][Full Text] [Related]
20. Long-lasting change in brain dynamics induced by methamphetamine: enhancement of protein kinase C-dependent astrocytic response and behavioral sensitization.
Narita M; Miyatake M; Shibasaki M; Tsuda M; Koizumi S; Narita M; Yajima Y; Inoue K; Suzuki T
J Neurochem; 2005 Jun; 93(6):1383-92. PubMed ID: 15935054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
